HIV Care

India is home to the world’s third largest population of people with HIV/AIDS, with approximately 2.5 million people living with the disease, of which fewer than 49% have access to treatment. Recognizing the critical need to further increase access to HIV/AIDS care in India, Taj Pharmaceuticals India launched its domestic business in 2009 with a comprehensive portfolio of ARVs, all of which are manufactured at Taj Pharma’s state-of-the-art facilities in India.